Clinical trial Recruiting at 1 site Interventional Ages 20 to 50

Disposable noninvasive skin closure to help healing and reduce scarring after plastic surgery

Official title: Disposable Noninvasive Skin Closure for Promoting Postoperative Wound Healing and Preventing Surgical Skin Scarring: A Single-Center, Prospective, Randomized Split-Scar, Self-Controlled Clinical Trial

Run by Peking University Third Hospital · NCT07849010 · Data updated 2026-11-12

This study tests a disposable noninvasive skin closure device on one side of a plastic surgery incision to see if it helps wounds heal better and results in less scarring.

Quick facts

Study typeInterventional
Ages20 Years to 50 Years
SexAll
Enrollment25 (estimated)
SponsorPeking University Third Hospital
Academic / other
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedOctober 8, 2026
Main results expectedJune 30, 2027
Study endsDecember 31, 2027
Registry record updatedOctober 9, 2026
Trial IDNCT07849010 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 20–50 undergoing plastic surgery with incisions >2 cm on the cheek, neck, trunk, or limbs (excluding hands/feet) and no history of abnormal scar formation.

Probably not a fit

Patients with autoimmune disease, prior abnormal scarring (keloids), wound infection, or use of other scar treatments during the study may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults undergoing plastic surgery with incisions longer than 2 cm on the face, neck, trunk, or limbs will be enrolled. Each incision is split, with the device applied to one half and standard care on the other half. Wound healing and scar appearance are evaluated at 1, 3, and 6 months by blinded plastic surgeons using standardized scar-rating tools. The study aims to determine the device’s safety and whether it improves healing and reduces scar formation compared with conventional care.

Why it matters

Potential benefit: If successful, the device could improve wound healing and reduce visible scarring after plastic surgery.

How similar studies have gone: Other studies in wound closure and scar prevention have shown potential benefits with new closure approaches, but this specific within-subject design is relatively novel for this device.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 20 to 50 years undergoing plastic surgery
* Surgical incision located on the cheek, neck, trunk, or limbs, excluding the hands and feet
* Surgical incision longer than 2 cm
* Willing and able to provide written informed consent

Exclusion Criteria:

* History of abnormal scar formation or keloids
* Autoimmune disease
* Surgical wound infection
* Use of any scar treatment or wound treatment other than the study device during the study period

Where it's running

  • Peking University Third Hospital
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

  • Principal investigator: Yimou Sun, M.D. — Peking University Third Hospital
  • Study coordinator: Yimou Sun, M.D.
  • Email: sym316@126.com
  • Phone: +86 13811625471

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.